AI Image
The evidence suggesting GLP-1s can curb drug and alcohol cravings
PBS • • business
Key Points:
- GLP-1 drugs, originally for diabetes and weight loss, are showing promise in reducing cravings for drugs and alcohol, potentially aiding addiction recovery.
- Dr. Steven Klein, a former addict and current physician, prescribes GLP-1s off-label to addiction patients, reporting reduced substance use and improved sobriety among many.
- A Rhode Island pilot program using telemedicine to provide GLP-1s to people with substance use disorders has seen significant decreases in cravings and increased well-being.
- NIH researchers are conducting clinical trials to understand how GLP-1s affect addiction cravings, with early data suggesting these drugs could be a game-changer in addiction medicine.
- Experts caution that while GLP-1s help, addiction recovery requires comprehensive support including therapy and community resources, and that long-term treatment may be necessary to prevent relapse.
